what meds are glp 1 New GLP-1 Guidelines for Type 2 Diabetes in 2025 Market Overview: GLP-1 Agonists and
Description
, Geary, N
If Phase 3 results confirm its safety and efficacy, it could reach the market within the next 12 years
PlexusDx patients typically see initial results within 48 weeks, with continued weight loss over 36 months of consistent treatment
The best results will always be those that come from adding diet and exercise to the treatment
Despite the side effects and murky insurance coverage, GLP-1s are becoming more common weight loss interventions
However, the incidence of gastrointestinal events, discontinuations due to adverse events, and mean increase in pulse rate were higher with orforglipron than oral semaglutide
